FDA NDA · NDA006170

HYPROTIGEN 5%

Sponsor: B BRAUN

APPLICATION

NDA006170

TYPE

NDA

ORIGINAL APPROVAL

1947-04-23

LATEST ACTION

1984-01-10

ROUTE

INJECTION

DOSAGE FORM

INJECTABLE

MARKETING STATUS

Discontinued

Products

HYPROTIGEN 5%Discontinued

PROTEIN HYDROLYSATE 5% · INJECTABLE · INJECTION

1984-01-10Manufacturing (CMC) · Supplement 6 · standardAP

1984-01-10Efficacy · Supplement 4 · standardAP

1984-01-10Labeling · Supplement 5 · standardAP

1947-04-23Type 5 - New Formulation or New Manufacturer · Original · standardAP

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.